| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |